Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Phase II
Merck & Co. (MRK) Poised To Enter Oral HCV Market Dominated by Gilead (GILD) and AbbVie (ABBV) 4/24/2015 6:22:34 AM
FDA Grants Orphan Drug Designation For DCR-PH1, Dicerna (DRNA)’s Investigational Therapy For The Treatment Of Primary Hyperoxaluria Type 1 (PH1) 4/23/2015 8:21:58 PM
Baseline Characteristics Of 228 Subjects Enrolled In MediciNova, Inc.'s Phase IIb Trial Of MN-166 (Ibudilast) In Progressive MS Presented At The American Academy of Neurology 67th Annual Meeting 4/23/2015 7:06:45 PM
Amgen (AMGN) Boasts 51% Rise in Profit, Abandons Phase II Brodalumb Study, but Pushes Biosimilars 4/22/2015 6:18:15 AM
Teva (TEVA) And Active Biotech AB (BTPC) Announce First Patient Enrolled In Phase II Study Evaluating Laquinimod For Primary Progressive MS 4/23/2015 1:17:55 PM
Mitotech Announces Phase 2 Data Showing Positive Effect Of SkQ1 In Patients With Dry Eye Syndrome 4/23/2015 11:56:56 AM
Intercept Ltd. Announces New FLINT Trial Data Showing OCA Treatment Increases Fibrosis Resolution And Cirrhosis Prevention In High-Risk NASH Patients 4/23/2015 10:56:08 AM
Conatus Pharma Clinical Results At EASL Meeting Support Emricasan Registration Pathway In NASH 4/23/2015 10:45:51 AM
Debiopharm Initiates Clinical Phase II Study Evaluating Debio 1450 In Staphylococcal Skin Infections 4/23/2015 9:01:14 AM
Ultragenyx Pharmaceuticals (RARE) Granted Additional Orphan Drug Designations For Triheptanoin 4/23/2015 7:47:35 AM
Merck & Co. (MRK) Touts Results From C-SURFER Phase II/III Clinical Trial 4/23/2015 6:02:06 AM
Gilead (GILD)’s Harvoni And Sovaldi Demonstrate Efficacy And Safety Among Chronic Hepatitis C Patients With Advanced Liver Disease 4/23/2015 6:28:11 AM
Merck & Co. (MRK) Announces Results From Phase 2/3 Study Of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir In Patients With Advanced Chronic Kidney Disease 4/23/2015 6:03:45 AM
Ultragenyx Pharmaceuticals (RARE) Announces Positive Data From Investigator-Sponsored Trial Of Triheptanoin In Glucose Transporter Type-1 Deficiency Syndrome 4/22/2015 8:22:21 AM
FDA, Genervon and ALS Blogger Battle Over Clinical Trial Interpretation 4/21/2015 6:52:00 AM